Atazanavir Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Atazanavir Atazanavir EP Impurity B VL2230001View CAS 127406-56-8
Atazanavir Atazanavir EP Impurity D VL2230003View
Atazanavir Atazanavir EP Impurity H VL2230009View
Atazanavir Atazanavir Impurity 1 VL2230005View CAS 1292296-09-3
Atazanavir Atazanavir Impurity 2 VL2230006View
Atazanavir Atazanavir Impurity 3 VL2230007View
Atazanavir Atazanavir Pyridinyl Benzoic acid Impurity VL2230010View CAS 4385-62-0
Atazanavir (E)-1-(4-(Pyridin-2-yl)benzylidene)hydrazine VE007002View CAS 257907-05-4

Request a quote

127406-56-8: Atazanavir EP Impurity B

127406-56-8: Atazanavir EP Impurity B
Catalogue No.

VL2230001

CAS No.

127406-56-8

Molecular Formula

C12H9NO

Molecular Weight

183.21

Parent drug

Atazanavir

IUPAC Name

4-(Pyridin-2-yl)benzaldehyde

Synonyms

N/A

References

Achenbach, Chad J., et al. Atazanavir/Ritonavir-Based Combination Antiretroviral Therapy for Treatment of HIV-1 Infection in Adults.” Future Virology, vol. 6, no. 2, Feb. 2011, pp. 157–77, https://doi.org/10.2217/fvl.10.89.

Status

In-stock

ListName

Atazanavir EP Impurity B

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url